INOVIO Pharmaceuticals Highlights Progress in Third Quarter 2025 Financial Results INOVIO Pharmaceuticals presents its financial results for Q3 2025, focusing on its advancements including the BLA for INO-3107 and new vaccine technologies.

INOVIO Pharmaceuticals Highlights Progress in Third Quarter 2025 Financial Results #USA #INOVIO #Plymouth_Meeting #INO-3107 #DNA_medicine

INOVIO Set to Participate in Upcoming Biotechnology Conference Focusing on DNA Medicines INOVIO, a leader in DNA medicine development, will join the Stephens Biotechnology Virtual Conference. Key management will discuss innovative healthcare solutions.

INOVIO Set to Participate in Upcoming Biotechnology Conference Focusing on DNA Medicines #United_States #biotechnology #INOVIO #Plymouth_Meeting #DNA_medicine

INOVIO Set to Showcase Innovations at Upcoming Scientific Conferences INOVIO will present its DNA medicine advancements, including its key candidate for HPV-related diseases, at notable upcoming conferences.

INOVIO Set to Showcase Innovations at Upcoming Scientific Conferences #United_States #INOVIO #Plymouth_Meeting #DNA_medicine #HPV

INOVIO Expands on Exciting 2025 Plans and 2024 Achievements in Biotech INOVIO Pharmaceuticals outlines key milestones for 2025, including its plans for new therapies and a successful 2024 in advancing DNA medicine.

INOVIO Expands on Exciting 2025 Plans and 2024 Achievements in Biotech #United_States #Plymouth_Meeting #RRP #INOVIO_Pharmaceuticals #DNA_medicine